Contact this trialFirst, we need to learn more about you.
Nucleoside Metabolic Inhibitor
Vorinostat + Azacitidine for Myelodysplastic Syndrome / Acute Myeloid Leukemia
Recruiting1 awardPhase 1 & 2
Bronx, New York
This trial is studying vorinostat and azacitidine to treat patients with myelodysplastic syndromes or acute myeloid leukemia.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service